Central Apnea in Patients Receiving Ticagrelor

Acute Coronary Syndrome Clinical Trial

Official title:

Central Apnea in Patients Receiving Ticagrelor

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03540459
• Other study ID #: Les Grands Prés
• Status: Recruiting
• Start date: April 1, 2018
• Est. completion date: September 30, 2020

Study information

• Verified date: February 2020
• Source: Les Grands Prés
• Contact: philippe meurin, MD
• Phone: +33674003218
• Email: philippemeurin[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

all patients with a left ventricular ejection fraction superior or equal to 50% less than 2 years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy

Description:

all patients with a left ventricular ejection fraction superior or equal to 50% less than 2 years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy the main objective of the study will be to look for central sleep apnea

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: September 30, 2020
• Est. primary completion date: September 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• patient receiving ticagrelor 10 days to 2 years after an acute coronary syndrome

Exclusion Criteria:

• left ventricular ejection fraction < 50%

• patients refusal

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Sleep Apnea, Central

Intervention

Diagnostic Test:
• sleep polygraphy
sleep polygraphy (one night) in all included patients

Locations

Country	Name	City	State
France	Les Grands Prés	Villeneuve Saint Denis

Sponsors (1)

Lead Sponsor	Collaborator
Les Grands Prés

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	central apnea index	mean central apnea index: apnea hypopnea index (AHI) is the scale commonly used to assess sleep disordered breathing.This scale includes central and obstructive apnea and hypopnea. The main outcome will be the central apnea index: number of central apnea per hour	at baseline
Secondary	global apnea hypopnea index	number of apnea and hypopnea per our	baseline